Calcium antagonists and renal disease  by Fournier, A. et al.
Letters to the Editor 2311
Correspondence to Albert Fournier, M.D., Ne´phrologie, Centre Hos-REFERENCES
pitalier Universitaire d’Amiens, Groupe Hospitalier Sud, Avenue Rene´
Lae¨nnec, Saloul, 80054 Amiens Cedex 1, France.1. Topham PS, Haydar , Kuphal R, Lightfoot JD, Salant DJ: Com-
plement-mediated injury reversibly disrupts glomerular epithelial
cell actin microfilaments and focal adhesions. Kidney Int 55:1763–
REFERENCES1775, 1999
2. Bains R, Furness P, Critchley D: A quantitative immunofluores- 1. Nzerue CM, Epstein M: Calcium antagonists and renal disease.
cence study of glomerular cell adhesion in proteinuric states. J Pathol (letter) Kidney Int 55:2074, 1999
183:272–280, 1997 2. Wentzel U, Helmchen V, Schoeppe W, Schwetzer G: Combina-
3. Gibbons R, Furness P, Critchley D: Redistribution of glomerular tion treatment of enalapril with nitrendipine in rats with renovascu-
epithelial cell adhesion molecules in membranous glomerulonephri- lar hypertension. Hypertension 23:114–122, 1994
tis. Histopathology 34:553–555, 1999 3. Rugginenti P, Perna A, Benini K, Remuzzi G, GISEN Group:
Effect of dihydropyridine calcium channel blockers, angiotensin
converting enzyme inhibition and blood pressure control on chronic
nondiabetic nephropathy. J Am Soc Nephrol 9:2096–2101, 1998
4. Zucchelli P, Zucchala A, Borghi M: Long-term comparison be-Calcium antagonists and tween captopril and nifedipine in the progression of renal insuffi-
ciency. Kidney Int 42:452–458, 1992
renal disease
To the Editor: Regarding the controversy between Major confounders forNzerue and Epstein [1] about the appropriate way to
evaluate the nephroprotective effect of antihypertensive reactance as a marker ofdrugs, we would like to point out the necessity of taking
into account drug-specific intraglomerular hemodynamic malnutrition infunctional alteration. This point is of particular relevance
to the comparison of the effects of calcium antagonists hemodialysis patientsand angiotensin-converting enzyme (ACE) inhibitors,
since the former increase glomerular filtration rate (GFR) To the Editor: We read with interest the paper by
by vasodilating afferent arterioles and the latter decrease Ikizler et al [1], which demonstrated that, in a 15-month
it by predominantly vasodilating efferent arterioles. In- follow-up period, the relative risk (RR) of hospitaliza-
deed, in the two kidney-one clip renovascular hyper- tion (that is, of morbidity) determined in 73 unselected
tension model, controlateral kidney GFR is lower with hemodialysis (HD) patients increased to 9% and 14%,
enalapril treatment than with nitrendipine treatment. as their reactance (Xc) value decreased from 70 Ohm
However, the reverse is true when GFR is measured (RR 5 1) to Xc 5 43, and Xc 5 31 Ohm, respectively.
after treatment is discontinued, indicative of a milder They correctly utilized the Xc component of the imped-
degree of glomerulosclerosis in the enalapril group [2]. ance vector as a marker of lean body mass.
The clinical relevance of this phenomenon has recently Unfortunately, Xc distribution, in either healthy or
been illustrated by the four-year follow-up results (pre- uremic humans with the same stature, is dependent on
sented at the last National Kidney Foundation meeting) race-ethnicity (higher in African Americans) [2], gender
of Parving’s study comparing nisoldipine and lisinopril (higher in women) [3, 4], body mass (lower in obese
in diabetic nephropathy. GFR significantly increased fol- patients) [4], and soft tissue hydration (higher in dehy-
lowing a 2-month discontinuation of treatment, but only dration, for example, with less dry weight) [3, 4] (Table
in the group given lisinopril. 1). For instance, obese HD patients (who are not mal-
Provided the mean arterial pressure is decreased be- nourished) had smaller Xc values than lean patients of
low 103 mm Hg, the antiproteinuric effect and the pre- the same gender, both before and after HD [3, 4]. In a
vention of GFR decline after 3 years of treatment with large American HD population, Xc values of women and
dihydropyridine or ACE inhibitor are equivalent [3, 4], men were comparable, but BMI of women was greater
but this may not necessarily reflect a similar structural (Table 1) [2].
nephroprotection. We suggest that GFR should also be We also observed reduced Xc values, both before and
measured after discontinuation of the antihypertensive after a HD session, in Caucasian patients with increased
treatment in ongoing trials with angiotensin (AT1) re- morbidity due to hemodynamic instability (symptomatic
ceptor blockers in order to prevent underestimation of hypotension episodes in 30% or more sessions) com-
their actual nephroprotective effect. pared to stable HD patients of the same race and gender,
with a same BMI, and with comparable or increasedA. Fournier, N. El Esper, A. Pruna, and J.M. Achard
resistance (R) values [3].Service de Ne´phrologie, CHU-80054 Amiens, France
In conclusion, Ikizler et al should prove that the cutoff
values they found in the whole population are stable
across gender, race-ethnicity, and with comparable tissue 1999 by the International Society of Nephrology
